Advanced Cell Tech. (ACTC) Receives Notice from U.S. FDA Regarding IND Application for Stem Cell Phase I/II to Treat SMD
Tweet Send to a Friend
Advanced Cell Technology, Inc. (OTCBB: ACTC) announced today that it has received notification from the US Food and Drug Administration ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
